Founded with a mission to simplify and scale the care of complex illnesses, RTHM offers virtual-first healthcare services targeting conditions such as Long COVID, ME/CFS, POTS, and mast cell activation. The company leverages telehealth to connect patients with specialized care teams and provides access to a wide range of therapies based on the latest research. RTHM aims to not only help patients manage symptoms but also to identify and treat root causes through innovative testing and early interventions. Their services are currently available in several U.S. states including California, Colorado, Washington, Oregon, New York, Florida, and Texas, with plans for further expansion.

RTHM has garnered attention for its impactful approach to complex illness care, attracting notable healthcare professionals and investors committed to advancing medical science and patient care. The organization has achieved significant milestones in patient outcomes through its collaborative partnerships and cutting-edge diagnostic tools. By focusing on both symptom management and root-cause treatments, RTHM has set a new standard in telehealth for complex conditions, making a profound impact on the lives of patients who often struggle to find effective care.